Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2005
12/28/2005CN1714096A Mmp inhibitors
12/28/2005CN1714093A Diazinopyrimidines
12/28/2005CN1714092A Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
12/28/2005CN1714084A Pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/28/2005CN1713915A Methods for preventing and treating bone loss with steroid compounds
12/28/2005CN1233410C External use medicine for bone-knitting
12/28/2005CN1233394C Rheumatic arthritis treating medicine
12/28/2005CN1233393C Bonesetting powder
12/28/2005CN1233381C Bone fracture analgesic ointment
12/28/2005CN1233379C Oral liquid for treating protrusion of the lumbar intervertebral disc
12/28/2005CN1233373C Chinese medicine composition for treating spondylodynia
12/28/2005CN1233365C External-use medicine for treating rheumatoid arthritis and its preparing method
12/28/2005CN1233341C Medicine compositions for treating LIDP
12/28/2005CN1233336C Chinese medicine for treating rheumatic arthritis
12/28/2005CN1233333C Process for preparing Tibetan medicines
12/28/2005CN1233325C Drug for treatment of osteonecrosis and for management of patients at risk of steonecrosis
12/28/2005CN1233323C Orally disintegrating tablet of meloxicam and its preparation
12/28/2005CN1233321C Rheumatism soft capsule and its preparation method
12/27/2005US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979539 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2005US6979447 Immunomodulation and effect on cell processes relating to serotonin family receptors
12/27/2005CA2305463C Aminobutanoic acid derivatives
12/22/2005WO2005121153A1 Condensed pyrimidine derivative and xanthine oxidase inhibitor
12/22/2005WO2005121135A1 Vla-4 inhibitor
12/22/2005WO2005121130A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005WO2005121123A1 Compounds as cor5 antagonists
12/22/2005WO2005121112A1 Medicinal compositions containing 6-hydroxybenz- bromarone or salts thereof
12/22/2005WO2005121076A1 (diaryl-methyl)-malononitriles and their use as estrogen receptor ligands
12/22/2005WO2005120522A1 Rheumatism preventive or therapeutic agent and beverage each comprising reduced-deuterium water
12/22/2005WO2005120485A1 Regulator of physiological function of ghrelin and use thereof
12/22/2005WO2005120484A1 Regulator for physiological functions of ghrelin
12/22/2005WO2005097814A3 Composition and method for inhibiting platelet aggregation
12/22/2005WO2005046569A3 Pharmaceutical compositions for the treatment of sars
12/22/2005WO2003057856A3 Dominant negative proteins and methods thereof
12/22/2005WO2002083874A3 Endothelial cell expression patterns
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005US20050282905 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient
12/22/2005US20050282900 Inhibitors of alpha4 mediated cell adhesion
12/22/2005US20050282882 Diamines as modulators of chemokine receptor activity
12/22/2005US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/22/2005US20050282872 Novel thyroid receptor ligands and method II
12/22/2005US20050282866 2,3-Diphenyl-1H-indole-5-carboxylic acid; I kappa B kinase inhibitor; decrease activation of nuclear factor (NF) kappa B; antiinflammatory agent: arthritis, osteoarthritis, asthma, cardiac infarct, Alzheimer's disease, carcinomateous disorders or atherosclerosis
12/22/2005US20050282861 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis
12/22/2005US20050282798 Pharmaceutical compounds
12/22/2005US20050282789 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system
12/22/2005US20050282786 Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations
12/22/2005US20050282783 Obtained by reacting sodium zoledronate with calcium orthophosphates in water, bone remodeling equilibrium; the local treatment of a bone problem on the main at-risk sites identified (neck of the femur )
12/22/2005US20050282255 Cell growth differentiation factor (MP52) for use in treatment and prevention of nervous system, dental, skin, connective tissue and bone disorders; wound healing agents
12/22/2005US20050282236 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/22/2005US20050282223 TR3-specific binding agents and methods for their use
12/22/2005US20050282165 Diagnosis of Carcinoma Using RAIG1 Polypeptides
12/22/2005US20050281910 Method for increasing pet activity
12/22/2005US20050281818 Method for the treatment of fibrosis
12/22/2005US20050281804 Administering human recombinant alpha -L-iduronidase, carrier and polysorbate for therapy of mucopolysaccharidosis
12/22/2005US20050281794 comprising a catechin (epigallocatechin gallate), an anti-oxidant (ascorbic acid), proline and lysine; cancer
12/22/2005CA2569887A1 Pyrrolopyridine derivatives
12/22/2005CA2569836A1 Herbal compositions for prevention and treatment of rheumatic and inflammatory diseases and method of preparing the same
12/22/2005CA2569678A1 Regulator of physiological function of ghrelin and use thereof
12/22/2005CA2569111A1 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005CA2567845A1 4-phenyl-pyrimidine-2-carbonitrile derivatives
12/22/2005CA2566772A1 (diaryl-methyl)-malononitriles and their use as estrogen receptor ligands
12/21/2005EP1607109A1 Multifunctional biodegradable composite and surgical implant comprising said composite
12/21/2005EP1607100A1 Remedy for spinal injury containing interleukin-6 antagonist
12/21/2005EP1606307A1 ESTRIENO(3,2-b)/(3,4-c)PYRROLE DERIVATIVES USEFUL AS MODULATORS OF THE ESTROGEN RECEPTORS
12/21/2005EP1606019A1 Cannabinoid receptor inverse agonists and neutral antagonists as therapeutic agents for the treatment of bone disorders
12/21/2005EP1605963A2 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof
12/21/2005EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/21/2005EP1463728A4 Fused cyclic modulators of nuclear hormone receptor function
12/21/2005EP1458723A4 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
12/21/2005EP1395558B1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
12/21/2005EP1389205B1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
12/21/2005EP1377567B1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
12/21/2005EP1313464A4 Method for treatment of reactive arthritis or bursitis
12/21/2005EP1265916B1 Therapeutic anti-cytomegalovirus compounds
12/21/2005EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors
12/21/2005EP1223915B1 Dry powder compositions having improved dispersivity
12/21/2005EP1218518B1 Dna polymerase lambda and uses thereof
12/21/2005EP1144431B1 16-hydroxyestratrienes as selective estrogens
12/21/2005EP1000143B1 Frazzled nucleotide sequences, expression products, compositions and uses
12/21/2005CN1711260A Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
12/21/2005CN1232532C Fibroblast growth factor-2 analogue, producing process and application thereof
12/21/2005CN1232507C Growth hormone secretagogues
12/21/2005CN1232503C Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
12/21/2005CN1232296C Chinese herbal medicinal preparation for curing sinew bone disease
12/21/2005CN1232290C Chinese medicine preparation of removing obstruction in the channels for treating atrophic arthritis
12/21/2005CN1232285C Chinese Medicine for treating cervical vertebra disease and its preparation method
12/21/2005CN1232281C Chinese medicine for treating primary osteoporosis resulted from deficiency of liver and kidney and its preparation method
12/21/2005CN1232276C Medicinal liquor for treating arthralgia
12/21/2005CN1232274C Medicine composition for prevention and cure of osteoporosis and its application
12/20/2005US6977294 Process for isolation of eupalitin from Boerhavia diffusa
12/20/2005US6977268 Diacid isoindoleine amide derivative
12/20/2005US6977267 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/20/2005US6977264 For therapy and prophylaxis of obesity, diabetes
12/20/2005US6977263 Chemical compounds
12/20/2005US6977256 Compounds and compositions as cathepsin S inhibitors
12/20/2005US6977084 Pet food containing Perna canaliculus for maintenance of joint health and alleviation of arthritic symptoms
12/15/2005WO2005119266A1 Sr-a antagonists
12/15/2005WO2005117906A1 Combination for inhibiting bone resorption comprising a bisphosponate (alendrona) and a vitamin d (cholecalciferol)
12/15/2005WO2005103263B1 Bone delivery conjugates and method of using same to target proteins to bone
1 ... 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 ... 820